AP2047A - Nodulisporic acid derivative spot-on formulations for combating parasites - Google Patents

Nodulisporic acid derivative spot-on formulations for combating parasites

Info

Publication number
AP2047A
AP2047A AP2005003289A AP2005003289A AP2047A AP 2047 A AP2047 A AP 2047A AP 2005003289 A AP2005003289 A AP 2005003289A AP 2005003289 A AP2005003289 A AP 2005003289A AP 2047 A AP2047 A AP 2047A
Authority
AP
ARIPO
Prior art keywords
formulations
acid derivative
combating parasites
nodulisporic acid
spot
Prior art date
Application number
AP2005003289A
Other languages
English (en)
Other versions
AP2005003289A0 (en
Inventor
Mark D Soll
Albert Boeckh
Bode Ronus De
Original Assignee
Merial Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Ltd filed Critical Merial Ltd
Publication of AP2005003289A0 publication Critical patent/AP2005003289A0/xx
Application granted granted Critical
Publication of AP2047A publication Critical patent/AP2047A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
    • A01N43/36—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom five-membered rings
    • A01N43/38—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom five-membered rings condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Agronomy & Crop Science (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Environmental Sciences (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AP2005003289A 2002-10-02 2003-09-29 Nodulisporic acid derivative spot-on formulations for combating parasites AP2047A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41562702P 2002-10-02 2002-10-02
US10/618,975 US20040077703A1 (en) 2002-10-02 2003-07-14 Nodulisporic acid derivative spot-on formulations for combating parasites
PCT/US2003/030500 WO2004030457A1 (en) 2002-10-02 2003-09-29 Nodulisporic acid derivative spot-on formulations for combating parasites

Publications (2)

Publication Number Publication Date
AP2005003289A0 AP2005003289A0 (en) 2005-06-30
AP2047A true AP2047A (en) 2009-09-18

Family

ID=32073382

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2005003289A AP2047A (en) 2002-10-02 2003-09-29 Nodulisporic acid derivative spot-on formulations for combating parasites

Country Status (22)

Country Link
US (1) US20040077703A1 (ja)
EP (1) EP1545211B1 (ja)
JP (1) JP2006502241A (ja)
KR (2) KR20050059235A (ja)
CN (1) CN100496244C (ja)
AP (1) AP2047A (ja)
AU (1) AU2003279002A1 (ja)
BR (1) BR0314531A (ja)
CA (1) CA2500822C (ja)
CO (1) CO5700750A2 (ja)
CR (2) CR7810A (ja)
EA (1) EA009683B1 (ja)
EC (1) ECSP055736A (ja)
ES (1) ES2482101T3 (ja)
GE (1) GEP20084414B (ja)
HK (1) HK1072348A1 (ja)
MA (1) MA27457A1 (ja)
MX (1) MXPA05003581A (ja)
NZ (1) NZ539227A (ja)
UA (1) UA83199C2 (ja)
WO (1) WO2004030457A1 (ja)
ZA (1) ZA200502904B (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9416065B2 (en) * 2007-02-12 2016-08-16 Archer Daniels Midland Company Adjuvants and methods of using them
ES2693696T3 (es) * 2007-11-26 2018-12-13 Merial, Inc. Sistemas de disolventes para formulaciones de unción dorsal continua para combatir parásitos
EP2875726A1 (fr) 2013-11-13 2015-05-27 Ceva Animal Health Nouvelles applications de compositions vétérinaires dans le traitement contre les parasites
KR101687973B1 (ko) 2015-12-08 2016-12-21 주식회사 씨티씨바이오 마이크로필름 코팅을 이용한 동물 사료용 프리믹스 제조방법
EP3688174A4 (en) * 2017-09-29 2021-09-08 Victoria Link Limited HETEROLOGICAL BIOSYNTHESIS OF NODULISPORIC ACID
KR102178885B1 (ko) * 2020-01-17 2020-11-13 강현준 카프릴산을 포함하는 안정한 해충 방제제 및 이의 제조방법

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996029073A1 (en) * 1995-03-20 1996-09-26 Merck & Co., Inc. Nodulisporic acid derivatives
WO1998012196A1 (en) * 1996-09-19 1998-03-26 Merck & Co., Inc. Nodulisporic acid derivatives

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3950360A (en) * 1972-06-08 1976-04-13 Sankyo Company Limited Antibiotic substances
SE434277B (sv) * 1976-04-19 1984-07-16 Merck & Co Inc Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis
US4199569A (en) * 1977-10-03 1980-04-22 Merck & Co., Inc. Selective hydrogenation products of C-076 compounds and derivatives thereof
JPS57139012A (en) * 1981-02-23 1982-08-27 Sankyo Co Ltd Anthelmintic composition
US4427663A (en) * 1982-03-16 1984-01-24 Merck & Co., Inc. 4"-Keto-and 4"-amino-4"-deoxy avermectin compounds and substituted amino derivatives thereof
EP0237482A1 (de) * 1986-03-06 1987-09-16 Ciba-Geigy Ag C(29)-Carbonyloxi-milbemycin-Derivate zur Bekämpfung von tier- und pflanzenparasitären Schädlingen
DE3767560D1 (de) * 1986-03-25 1991-02-28 Sankyo Co Makrolide verbindungen, ihre herstellung und verwendung.
GB8613914D0 (en) * 1986-06-07 1986-07-09 Coopers Animal Health Liquid formulations
EP0252879B1 (de) * 1986-07-02 1992-05-06 Ciba-Geigy Ag Pestizide
US4855317A (en) * 1987-03-06 1989-08-08 Ciba-Geigy Corporation Insecticides and parasiticides
US4871719A (en) * 1987-03-24 1989-10-03 Ciba-Geigy Corporation Composition for controlling parasites in productive livestock
DE3888936T2 (de) * 1987-11-03 1994-07-21 Beecham Group Plc Zwischenprodukte für die Herstellung makrolider Antibiotika mit anthelmintischer Wirkung.
NZ232422A (en) * 1989-02-16 1992-11-25 Merck & Co Inc 13-ketal milbemycin derivatives and parasiticides
CA2036147A1 (en) * 1990-06-29 1991-12-30 Hiroki Tomioka A 1-pyridylimidazole derivative and its production and use
GB9205007D0 (en) * 1992-03-07 1992-04-22 Pfizer Ltd Antiparasitic agents
GB9300883D0 (en) 1993-01-18 1993-03-10 Pfizer Ltd Antiparasitic agents
ATE180491T1 (de) * 1993-02-19 1999-06-15 Hoffmann La Roche Racemisierungsfreie herstellung von amiden und peptiden in gegenwart katalytischer mengen einer n-hydroxy-verbindung
GB9315108D0 (en) * 1993-07-21 1993-09-01 Pfizer Ltd Antiparasitic agents
US5399582A (en) * 1993-11-01 1995-03-21 Merck & Co., Inc. Antiparasitic agents
GB9402916D0 (en) * 1994-02-16 1994-04-06 Pfizer Ltd Antiparasitic agents
JPH0827018A (ja) * 1994-07-22 1996-01-30 Sanwa Kagaku Kenkyusho Co Ltd 生理活性ペプチド又は蛋白質を含有する薬剤組成物
AUPM969994A0 (en) * 1994-11-28 1994-12-22 Virbac S.A. Equine anthelmintic formulations
US5595998A (en) * 1994-12-15 1997-01-21 Wolin; Ronald L. Pyrazoloquinolines
US5962499A (en) * 1995-03-20 1999-10-05 Merck & Co., Inc. Nodulisporic acid derivatives
US5595991A (en) * 1995-03-20 1997-01-21 Merck & Co., Inc. Anthelmintic use of nodulisporic acid and analogs thereof
US6221894B1 (en) * 1995-03-20 2001-04-24 Merck & Co., Inc. Nodulisporic acid derivatives
FR2739255B1 (fr) * 1995-09-29 1998-09-04 Rhone Merieux Composition antiparasitaire pour le traitement et la protection des animaux de compagnie
IE80657B1 (en) * 1996-03-29 1998-11-04 Merial Sas Insecticidal combination to control mammal fleas in particular fleas on cats and dogs
US6010710A (en) * 1996-03-29 2000-01-04 Merial Direct pour-on skin solution for antiparasitic use in cattle and sheep
US5885607A (en) * 1996-03-29 1999-03-23 Rhone Merieux N-phenylpyrazole-based anti-flea and anti-tick external device for cats and dogs
US5834260A (en) * 1996-08-30 1998-11-10 Merck & Co., Inc. Antiparasitic agents
US6426333B1 (en) * 1996-09-19 2002-07-30 Merial Spot-on formulations for combating parasites
FR2753377B1 (fr) * 1996-09-19 1999-09-24 Rhone Merieux Nouvelle association parasiticide a base de 1-n-phenylpyra- zoles et de lactones macrocycliques endectocides
US6136838A (en) * 1998-03-19 2000-10-24 Merck & Co., Inc. Sulfurpentafluorophenylpyrazoles for controlling ectoparasitic infestations
JP3510591B2 (ja) * 1998-03-30 2004-03-29 エルジ ケミカル リミテッド ポリエトキシル化レチンアミド誘導体およびその製造方法
US6399796B2 (en) * 2000-03-17 2002-06-04 Roche Vitamins Inc. Activation of a Diels-Alder reaction of a sterol 5,7-diene
US6399786B1 (en) * 2000-07-14 2002-06-04 Merck & Co., Inc. Nonacyclic nodulisporic acid derivatives
US20040037869A1 (en) * 2002-08-16 2004-02-26 Douglas Cleverly Non-animal product containing veterinary formulations
US20050234119A1 (en) * 2004-04-16 2005-10-20 Soll Mark D Antiparasitical agents and methods for treating, preventing and controlling external parasites in animals
US20080003282A1 (en) * 2005-04-18 2008-01-03 Soll Mark D Antiparasitical agents and methods for treating, preventing and controlling external parasites in animals

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996029073A1 (en) * 1995-03-20 1996-09-26 Merck & Co., Inc. Nodulisporic acid derivatives
WO1998012196A1 (en) * 1996-09-19 1998-03-26 Merck & Co., Inc. Nodulisporic acid derivatives

Also Published As

Publication number Publication date
EP1545211A1 (en) 2005-06-29
CA2500822A1 (en) 2004-04-15
CA2500822C (en) 2013-12-24
EP1545211B1 (en) 2014-04-30
HK1072348A1 (en) 2005-08-26
ES2482101T3 (es) 2014-08-01
US20040077703A1 (en) 2004-04-22
WO2004030457A1 (en) 2004-04-15
MXPA05003581A (es) 2005-06-17
KR20070099668A (ko) 2007-10-09
UA83199C2 (ru) 2008-06-25
EA200500579A1 (ru) 2005-08-25
CO5700750A2 (es) 2006-11-30
AP2005003289A0 (en) 2005-06-30
KR20050059235A (ko) 2005-06-17
CN100496244C (zh) 2009-06-10
ECSP055736A (es) 2005-09-20
JP2006502241A (ja) 2006-01-19
CR7810A (es) 2005-05-25
MA27457A1 (fr) 2005-07-01
AU2003279002A1 (en) 2004-04-23
EA009683B1 (ru) 2008-02-28
ZA200502904B (en) 2005-10-19
GEP20084414B (en) 2008-07-10
BR0314531A (pt) 2005-08-09
NZ539227A (en) 2007-01-26
CN1700859A (zh) 2005-11-23
CR10319A (es) 2008-10-21

Similar Documents

Publication Publication Date Title
AU2003215334A1 (en) Inhalable formulations for sustained release
AP2441A (en) Low-faoming aqueous formulations used for crop protection
EP1383376A4 (en) PHARMACEUTICAL FORMULATIONS WITH PROLONGED RELEASE
IL166424A0 (en) Sustained release formulations comprising lamotigine
IL164519A0 (en) Pharmaceutical formulations
HK1092703A1 (en) Stabilized formulations of phosphatidylserine
IL172824A0 (en) Pharmaceutical formulations
GB0302671D0 (en) Pharmaceutical formulations
ZA200503546B (en) Tiotropium containing HFC solution formulations
IL180031A0 (en) Stable pharmaceutical formulations of benzimidazole compounds
SI1536783T1 (sl) Trdne formulacije, ki vsebujejo indolinonsko spojino
AU2003279911A1 (en) Therapeutic formulations
HK1072348A1 (en) Nodulisporic acid derivative spot-on formulations for combating parasites
GB0218930D0 (en) Pharmaceutical formulations
IL165069A0 (en) Immediate release pharmaceutical formulation
GB0302672D0 (en) Pharmaceutical formulations
GB0202900D0 (en) Novel formulations of drugs
GB0316341D0 (en) Pharmaceutical formulations
IL174308A0 (en) Therapeutic formulations
EP1448203A4 (en) PHARMACEUTICAL PREPARATIONS COMPRISING SUBSTITUTED XANTHIN COMPOUNDS
GB0226076D0 (en) Improved formulations containing substituted imidazole derivatives
AU2003295846A8 (en) Pharmaceutical formulations of celcoxib
AU2003238896A1 (en) Stabilized pharmaceutical compositions containing benzimidazole compounds
GB0214147D0 (en) Formulations
AU2003231306A8 (en) Carvedilol formulations